Home #1 #2 #3 #4 #5 #6 #7 #8 #9 #10

Proof Of Cancer Harvesting


Nuclear Overthrow and The Cancer Harvest

The antennae are to put you to sleep...

http://artificialtelepathy.blogspot.com

...get rid of your cell phones and all the towers or die...



The oil from iraq was not needed for your cars, it was needed for mega-electricity to run the antennae, its called electronic behaviour modification, they sell it as law enforcement: this was to keep you from rising up until they could get the nukes hooked up...you are on your way to a premature grave as this is being written...soon the nukes, then you go bye bye...Watch Florida, it is first for all of this bushit....like this:


NO CANCER TISSUE HARVESTED FROM ANY PATIENT GOES TO WASTE. All tumors are used and very much in demand.

The world governments goal is to be able to create cancer in anyone, thereby not only imposing a death sentence on that person, but also their descendents, because anyone with cancer in their family is being surreptiously marked and electronically annotated as genetically unfit.

This is all smoke and mirrors, because cancer is easily curable, though anyone who mentions that is run out of the country. Cancer is the biggest industry in America, but it is simply make-work for ghouls, and a means to rewrite many medical laws. The repositorys and tumor banks number in the many thousands, just in the United states alone.

This was investigated because of recent revelations concerning stem cells and human cancer tumors. Cancer tumors are needed to obtain certain types of stem cells and other cells necessary to create longevity drugs for the worlds elite. Also aborted foetuses are needed too. They will lie about this connection of course, but the evidence points to the fact that this kind of research and use of tumors is very developed and gone well beyond the early stages.

A search for tumor repositorys brought back over 300,000 results. A search for tumor banks almost as many. Collection activities seem to be most refined in Florida of all places. Most of the legislation concerning this medical work was done during clintons time....fyi. Cancers are many times caused by excessive radiations. The excessive radiations of ENMOD began in clintons times too.



-----------------------


As we can see from the information below, cancer tumors of all types are lucrative for the pharmaceutical industry because of the odd cellular forms they sometimes produce, and it therefore behooves the profit minded to make NEW AND DIFFERENT KINDS OF CANCERS, for their ghoulish medicines and developments.


Are you people getting this yet? They are using ENMOD and CELL PHONES to inundate you with cancer causing radiations day in and day out, to see what will grow on you and in you. You of course will go to them to have the tumor removed, where else are you going to go, and they are going to put you in DEBT to do it. If ENMOD and Antennae tower radiation doesn't accomplish this quickly enough, they have all kinds of buggies too, and its no coincidence that 10 of the top 12 most-frequently-used bioterror agents (CDC) cause SKIN CANCER...easily harvestable and prone to accelerated growths from irradiation....How many people do you know have cancer? How many have had cancers cut off? Just in the last 6 years say? This dovetails with skull n bones philosophy and the republican addage PREY: IT WORKS!



Some of the below are for actual treatment of tumors, but many illustrate well the fact that tumor tissue of all types is required and used for many pharmaceutical concoctions.

Ê Searching US Patent Collection... Results of Search in US Patent Collection db for:

"stem cell" AND tumor: 3921 patents.

Hits 1 through 50 out of 3921

United States Patent 7,071,004

Meyers , Ê et al. July 4, 2006

14094, a novel human trypsin family member and uses thereof


Abstract

The invention provides isolated nucleic acids molecules, designated 14094 nucleic acid molecules, which encode a novel trypsin family member.

********Elevated expression of 14094 mRNA was detected in breast, ovarian, lung, and liver cancers compared to normal cells derived from these tissues. **********

The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 14094 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 14094 gene has been introduced or disrupted. The invention still further provides isolated 14094 proteins, fusion proteins, antigenic peptides and anti-14094 antibodies. Therapeutic and diagnostic methods utilizing compositions of the invention to, for example, treat, prevent, and/or diagnose neoplastic conditions, are also provided.


Inventors: Meyers; Rachel (Newton, MA); Macbeth; Kyle J. (Boston, MA)

Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)

Appl. No.: 846512

Filed: May 1, 2001

----------------------------------------------

United States Patent 7,074,615

Chaney , Ê et al. July 11, 2006 Peptides for enhanced cell attachment and cell growth Appl. No.: 641286 Filed: August 15, 2003 Current U.S. Class: 435/402 ; 435/404; 514/17; 514/2; 530/330; 530/345; 530/402 Current International Class: A61K 38/08Ê(20060101); A61K 38/04Ê(20060101); C07K 17/08Ê(20060101); C12N 5/00Ê(20060101); C12N 5/06Ê(20060101) Field of Search: 435/325,7.1,402,404 514/2,17 530/350,345 The compositions and the methods utilizing CAP peptide-modified CAR surfaces, as described herein, are applicable to the analyze the attachment, growth and/or differentiation of any adherent cell type, and may be used to culture such cells for intervals of varying duration. Example 1 below focuses on two particular cells types" (1) the almost ubiquitous NIH3T3 fibroblast cell line and (2) the more "specialized" MC3T3 osteoblast cell line. However, as intended, this invention is equally applicable to any cell type,


****************** whether (i) a primary culture of cells derived from a tissue or tumor explant ***********,


or from any body cavity or fluid, (ii) a cell type that can be maintained in culture for a limited period before senescence, or (iii) an immortalized long term cell line. Preferred types of cells include liver or liver derived cells such as primary hepatocytes, neuronal cells, neuronal stem cells, mesenchymal stem cells, pancreatic cells, skeletal muscle cells, cardiomyocytes, liver epithielial cells (a source of stem cells), HepG2 cells,

************ a hepatocellular carcinoma-derived cells line....**************

--------------------------------


--------------------------------

PAT. NO. Title 1 7,078,592 Ê Nucleic acids encoding coleopteran-toxic polypeptides and insect-resistant transgenic plants comprising them 2 7,078,585 Ê Bacterial cell component-unresponsive model mouse 3 7,078,506 Ê Canineil-4nucleic acid molecules and uses thereof 4 7,078,496 Ê Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith 5 7,078,492 Ê Human antipneumococcal antibodies from non-human animals 6 7,078,483 Ê Retroviral vectors including modified envelope escort proteins 7 7,078,481 Ê Potassium channel interactors and uses therefor 8 7,078,375 Ê Diabetes-mediating proteins and therapeutic uses thereof 9 7,078,231 Ê Human pancreatic epithelial progenitor cells and methods of isolation and use thereof 10 7,078,206 Ê UDP-N-acetylglucosamine: galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-R/ (GlcNAc to GalNAc) .beta.1,6N-acetylglucosaminyltransferase, C2GnT3 11 7,078,205 Ê NUCLEIC ACID SEQUENCES ENCODING MELANOMA ASSOCIATED ANTIGEN MOLECULES, AMINOTRANSFERASE MOLECULES, ATPASE MOLECULES, ACYLTRANSFERASE MOLECULES, PYRIDOXAL-PHOSPHATE DEPENDENT ENZYME MOLECULES AND USES THEREFOR 12 7,078,196 Ê RNA interference mediating small RNA molecules 13 7,078,179 Ê Selectable gene marker system based on expression of N-acetyllactosaminide 3-.alpha. galactosyltransferase 14 7,078,041 Ê Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same 15 7,078,035 Ê Phytases, nucleic acids encoding them and methods for making and using them 16 7,078,032 Ê Delivery of therapeutic biologicals from implantable tissue matrices 17 7,074,912 Ê Secreted and transmembrane polypeptides and nucleic acids encoding the same 18 7,074,911 Ê Endogenous granzyme B in non-immune cells 19 7,074,910 Ê PRO4340 nucleic acids 20 7,074,909 Ê Antibodies 21 7,074,908 Ê Protein specific for cardiac and skeletal muscle 22 7,074,901 Ê Isolated human vCOL16A1 polypeptide and fragments thereof 23 7,074,897 Ê Pro943 polypeptides 24 7,074,789 Ê Kinase inhibitors 25 7,074,615 Ê Peptides for enhanced cell attachment and cell growth 26 7,074,593 Ê PRO 703 nucleic acids 27 7,074,592 Ê Secreted and transmembrane polypeptides nucleic acid encoding 28 7,074,575 Ê Use of interleukin-19 to treat ovarian cancer 29 7,074,571 Ê Serine carboxypeptidase hx (SCPhx) and compositions thereof 30 7,074,554 Ê Antibodies specific for NEBR1 and methods of use thereof 31 7,074,553 Ê Retrovirus associated with myelodysplastic syndromes and uses thereof 32 7,074,438 Ê Compositions for oral delivery of nutrients and pharmaceuticals 33 7,074,405 Ê Use of bi-specific antibodies for pre-targeting diagnosis and therapy 34 7,074,403 Ê Immunotherapy of autoimmune disorders using antibodies which target B-cells 35 7,074,397 Ê Method for enhancing proliferation or differentiation of a cell using ob protein 36 7,071,373 Ê Transgenic ungulate compositions and methods 37 7,071,335 Ê 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain 38 7,071,317 Ê Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods 39 7,071,308 Ê Cytokine receptor 40 7,071,304 Ê Secreted and transmembrane polypeptides and nucleic acids encoding the same 41 7,071,303 Ê Androgen regulated prostate specific nucleic acids 42 7,071,301 Ê Chimeric viral receptor polypeptides, human viral receptor polypeptides and uses thereof 43 7,071,300 Ê IGF antagonist peptides 44 7,071,172 Ê Secretion signal vectors 45 7,071,160 Ê Insulin-like growth factor-binding protein 46 7,071,004 Ê 14094, a novel human trypsin family member and uses thereof

----------------------


------------------------------------------